4.5 Article

Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 13, 期 2, 页码 243-249

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.1c00598

关键词

A(3) Adenosine receptors; Adenosine antagonists; Pyrimidines; Ugi reaction; Multicomponent reactions

资金

  1. Conselleria de Cultura, Educacion e Ordenacion Universitaria [Galician Government] [ED431B 2020/43]
  2. Xunta de Galicia (Centro singular de investigacion de Galicia accreditation 2019-2022) [ED431G 2019/03]
  3. European Union (European Regional Development Fund -ERDF)
  4. Swedish Research Council [521-2014-2118]
  5. Swedish strategic research program eSSENCE
  6. EU COST action ERNEST [CA18133]

向作者/读者索取更多资源

This study designed a library of highly selective pyrimidine-based compounds to explore non-orthosteric interactions within the A3AR receptor. Through structure-based design, the solubility of the synthesized compounds was improved, and the impact of functionalized residues on structural tolerability was evaluated. The study provides clues for further development of novel A3AR ligands.
: A library of potent and highly A3AR selective pyrimidinebased compounds was designed to explore non-orthosteric interactions within this receptor. Starting from a prototypical orthosteric A3AR antagonist (ISVY130), the structure-based design explored functionalized residues at the exocyclic amide L1 region and aimed to provide additional interactions outside the A3AR orthosteric site. The novel ligands were assembled through an efficient and succinct synthetic approach, resulting in compounds that retain the A3AR potent and selective profile while improving the solubility of the original scaffold. The experimentally demonstrated tolerability of the L1 region to structural functionalization was further assessed by molecular dynamics simulations, giving hints of the non-orthosteric interactions explored by these series. The results pave the way to explore newly functionalized A3AR ligands, including covalent drugs and molecular probes for diagnostic and delivery purposes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据